| abstract |
Described herein are compounds and methods for treating or preventing neurological, otic and ophthalmic diseases in a subject. Compounds that can be used as therapeutic agents are also described herein. As used herein, compounds comprising taurine and / or cysteic acid residues and protease inhibitor or calpain inhibitor residues that can be directly linked to each other or indirectly linked to each other, and of such compounds Pharmaceutically acceptable salts are disclosed. |